CIK 0001478320 · Large accelerated filer
Adaptive Biotechnologies Corp
Sign in to watch- Ticker
- ADPT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- operating
- EIN
- 270907024
- Phone
- 206-659-0067
- Business address
- 1165 EASTLAKE AVE E, SEATTLE, WA, 98109
- Former names
- Adaptive TCR Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $32,383,812
- in 18 filings, $13.4M under 10b5-1 plans
Net −$32,383,812. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-13 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −11,881 | $25.50 | $303K | 377,802 |
| 2026-10-13 | RUBINSTEIN JULIE President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −11,881 | 272,848 | ||
| 2026-10-12 | RUBINSTEIN JULIE President and COO | Option exercise 10b5-1 | +11,881 | $12.14 | $144K | 389,683 |
| 2026-10-12 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −9,181 | $25.35 | $233K | 380,502 |
| 2026-10-12 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −2,700 | $26.07 | $70K | 377,802 |
| 2026-10-12 | RUBINSTEIN JULIE President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −11,881 | 284,729 | ||
| 2026-10-09 | RUBINSTEIN JULIE President and COO | Option exercise 10b5-1 | +11,881 | $12.14 | $144K | 389,683 |
| 2026-10-09 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −11,881 | $26.41 | $314K | 377,802 |
| 2026-10-09 | RUBINSTEIN JULIE President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −11,881 | 296,610 | ||
| 2026-10-08 | RUBINSTEIN JULIE President and COO | Option exercise 10b5-1 | +11,881 | $12.14 | $144K | 389,683 |
| 2026-10-08 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −11,881 | $25.66 | $305K | 377,802 |
| 2026-10-08 | RUBINSTEIN JULIE President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −11,881 | 308,491 | ||
| 2026-10-07 | RUBINSTEIN JULIE President and COO | Option exercise 10b5-1 | +11,881 | $12.14 | $144K | 389,683 |
| 2026-10-07 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −11,881 | $26.40 | $314K | 377,802 |
| 2026-10-07 | RUBINSTEIN JULIE President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −11,881 | 320,372 | ||
| 2026-10-06 | BOBULSKY SUSAN Chief Commercial Officer, MRD | Sale 10b5-1 | −6,444 | $30.00 | $193K | 389,350 |
| 2026-10-06 | RUBINSTEIN JULIE President and COO | Option exercise 10b5-1 | +11,881 | $12.14 | $144K | 389,683 |
| 2026-10-06 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −9,381 | $27.36 | $257K | 380,302 |
| 2026-10-06 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −1,100 | $28.21 | $31K | 379,202 |
| 2026-10-06 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −901 | $29.71 | $27K | 378,301 |
Page 5 of 119 · 2,375 trades